entity

Tau-Mediated Neurodegeneration

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Tau-Mediated Neurodegeneration: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

16Connections
1Hypotheses
0Analyses
0Outgoing
9Incoming

Wiki Pages (20)

Knowledge base pages for this entity

coq10-neurodegeneration

therapeutic · 5142 words

Lithium for PSP/CBS — Phase 2 Trial

clinical · 4474 words

tudca-udca-neurodegeneration

therapeutic · 3718 words

PRX005

entity · 3656 words

tau-hyperphosphorylation

mechanism · 3543 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (16)

SourceRelationTypeStr
APOE4associated_withprotein0.95
APOEregulatesgene0.95
Trem2-Independent Microgliosispromotesprocess0.90
Microgliacontributes_tocell_type0.90
Gut Microbiotacontributes_toprocess0.88

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
CYP46A1 Suppression for Tau-Mediated Neurodegeneration 0.494 neurodegeneration Lipid raft composition changes in synapt

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found